Insider Trading May 11, 2026 07:10 PM

Alphatec Director Executes Near $1 Million in Common Stock Purchases

Keith Valentine acquires significant stake in ATEC amid recent earnings volatility and trading near 52-week lows.

By Ajmal Hussain ATEC

Keith Valentine, a director at Alphatec Holdings, Inc. (NASDAQ: ATEC), has completed a series of transactions totaling $996,192 in common stock. These acquisitions occurred over a four-day period in May 2026, even as the company's share price traded near its 52-week low. The buying activity follows a Q1 earnings report that showed an earnings per share beat but a revenue miss.

Alphatec Director Executes Near $1 Million in Common Stock Purchases
ATEC

Key Points

  • Director Keith Valentine invested nearly $1 million in ATEC common stock through multiple transactions in May 2026.
  • Alphatec reported a Q1 EPS of $0.00, beating the expected -$0.02, but missed revenue targets by 2.79%.
  • The stock is currently trading near its 52-week low of $6.82, with analysts projecting a Fair Value of $8.65 and profitability this year.

Alphatec Holdings, Inc. (NASDAQ: ATEC) has seen significant insider activity following recent financial disclosures. Keith Valentine, a director of the company, has executed multiple direct acquisitions of common stock, amounting to a total investment of $996,192.

The transactions took place between May 7 and May 11, 2026. During this window, Mr. Valentine acquired shares at various price points ranging from a low of $7.00 to a high of $7.54 per share. This influx of capital from an internal director comes at a time when ATEC is trading at $6.99, positioned near its 52-week low of $6.82.


Breakdown of Transaction Activity

The purchasing pattern was spread across three distinct dates in May:

  • May 7, 2026: Mr. Valentine initiated the buying with 56,153 shares. These were acquired at a weighted average price of $7.49, with individual transactions fluctuating between $7.48 and $7.50 per share.
  • May 8, 2026: An additional 43,847 shares were purchased. The weighted average for this lot was $7.54, with specific transaction prices ranging from $7.52 to $7.55.
  • May 11, 2026: The final reported acquisition involved 35,000 shares, which were bought at a price of $7.00 per share.

All of these transactions are classified as direct acquisitions of common stock.


Financial Context and Earnings Performance

The insider buying follows Alphatec's announcement regarding its Q1 2026 earnings, a report that presented a mixed financial picture. On the profitability front, the company reported an earnings per share (EPS) of $0.00. This figure exceeded market expectations, which had anticipated an EPS of -$0.02, representing a 100% surprise relative to analyst forecasts.

However, revenue performance did not align with projections. Alphatec Holdings reported revenue of $192.11 million, which fell short of the estimated $197.63 million by 2.79%. This discrepancy between earnings beats and revenue misses has made the company's recent disclosures a focal point for industry observers and investors.


Market Valuation and Projections

Despite the current trading price, some analytical models suggest potential value in the stock. Analysis indicates that ATEC may be undervalued with an estimated Fair Value of $8.65. Furthermore, analyst projections suggest a path toward profitability for the company this year, with a forecasted EPS of $0.33.


Key Market Observations

  • Insider Confidence: The substantial direct investment by a director during a period of low share pricing may signal internal perspective on current valuation levels.
  • Growth vs. Profitability: The divergence between the EPS surprise and the revenue shortfall highlights the ongoing tension between managing bottom-line profitability and achieving top-line growth targets in the healthcare/tech sector.

Risk Factors and Uncertainties

  • Revenue Shortfalls: The 2.79% miss in projected revenue indicates potential challenges in meeting market demand or scaling operations as expected, which could impact broader sector confidence.
  • Price Volatility: With the stock trading near its 52-week low, there remains uncertainty regarding whether current levels represent a floor or if downward pressure will continue.

Risks

  • Revenue underperformance relative to analyst expectations suggests potential headwinds in top-line growth.
  • The stock's proximity to its 52-week low reflects recent market volatility and valuation concerns.

More from Insider Trading

Edwards Lifesciences CEO Executes Multi-Million Dollar Share Sale via Pre-Set Trading Plan May 12, 2026 Covista CFO Executes $1.26 Million Stock Sale via Pre-Scheduled Trading Plan May 12, 2026 Covista Executive Executes Planned Share Sale Amidst Corporate Growth and Financial Restructuring May 12, 2026 Covista Executive Executes $1.22 Million Stock Sale Under Pre-Planned Trading Program May 12, 2026 Ameriprise Financial Director Executes Stock Sale Amid Strong Earnings Performance May 12, 2026